As mentioned above, FBP1 can translocate into the nucleus to inhibit the function of HIF in VHL-deficient ccRCC, while FBP1 is degraded by CUL4B via ubiquitin-mediated proteasomal degradation. Here, FBP1 is linked to nonpapillary renal cell carcinoma.